Narcotic antagonists: a reasonable method of treating narcotic dependency.
Historically, narcotic dependence has been treated primarily by substituting one narcotic drug for another. One alternative chemical treatment for narcotic dependency is through the use of a narcotic antagonist. The present study involves the observed side effects and outcome results of treating 40 male heroin addicts with the narcotic antagonist, cyclazocine, in the context of a comprehensive psychotherapeutic program. It is concluded that the side effects of cyclazocine are minimal, that cyclazocine is not diverted to the streets, and that it is an effective tool in the context of a comprehensive treatment program for narcotic-dependent individuals.
D000359:Aftercare; D003496:Cyclazocine / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005059:Euphoria / Q000187:drug effects; D006556:Heroin Dependence / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008505:Medical Staff, Hospital / Q000193:education; D008691:Methadone / Q000627:therapeutic use; D010349:Patient Compliance; D011567:Psychiatric Department, Hospital; D011613:Psychotherapy; D014505:Urban Population
D003496:Cyclazocine; D008691:Methadone